Similar to tumor-bearing mice, KVK vaccination in combination with anti-NKG2A resulted in reduced E7-specific CD8 T cells in the three peripheral compartments as well as the functionality of splenic antigen-specific CD8 T cells (Supplementary Figure S5A,B). This evidence concerns the gene CD8A and neoplasm.